Literature DB >> 15280505

Multiplicity of human immunodeficiency virus infections in lymphoid tissue.

Narendra M Dixit1, Alan S Perelson.   

Abstract

Human immunodeficiency virus type 1 (HIV-1)-infected splenocytes in humans were recently shown to harbor three to four proviruses per cell on average (A. Jung et al., Nature 418:144, 2002). However, the mechanisms that lead to such extensive multiple infections are not understood. Here, we find by using mathematical analysis that two mechanisms quantitatively capture the distribution of proviral genomes in HIV-1-infected splenocytes, one where multiple genomes are acquired one at a time in a series of sequential infectious contacts of a target cell with free virions and infected cells, and the other where cell-to-cell transmission of multiple virions or genomes results from a single infectious contact of a target cell with an infected cell. The two mechanisms imply different genetic diversities of proviruses within an infected cell and therefore different rates of emergence of drug resistance via recombination.

Entities:  

Mesh:

Year:  2004        PMID: 15280505      PMCID: PMC479058          DOI: 10.1128/JVI.78.16.8942-8945.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  11 in total

1.  Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes.

Authors:  V Piguet; F Gu; M Foti; N Demaurex; J Gruenberg; J L Carpentier; D Trono
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

2.  Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy.

Authors:  Mark J Miller; Sindy H Wei; Michael D Cahalan; Ian Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

3.  Recombination: Multiply infected spleen cells in HIV patients.

Authors:  Andreas Jung; Reinhard Maier; Jean-Pierre Vartanian; Gennady Bocharov; Volker Jung; Ulrike Fischer; Eckart Meese; Simon Wain-Hobson; Andreas Meyerhans
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

4.  Dynamics of HIV-1 recombination in its natural target cells.

Authors:  David N Levy; Grace M Aldrovandi; Olaf Kutsch; George M Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

5.  The Trojan exosome hypothesis.

Authors:  Stephen J Gould; Amy M Booth; James E K Hildreth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-28       Impact factor: 11.205

Review 6.  Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues.

Authors:  A T Haase
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

7.  HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.

Authors:  A S Perelson; A U Neumann; M Markowitz; J M Leonard; D D Ho
Journal:  Science       Date:  1996-03-15       Impact factor: 47.728

8.  Dynamics of HIV infection of CD4+ T cells.

Authors:  A S Perelson; D E Kirschner; R De Boer
Journal:  Math Biosci       Date:  1993-03       Impact factor: 2.144

9.  CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef.

Authors:  B K Chen; R T Gandhi; D Baltimore
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

10.  Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways.

Authors:  Que Dang; Jianbo Chen; Derya Unutmaz; John M Coffin; Vinay K Pathak; Douglas Powell; Vineet N KewalRamani; Frank Maldarelli; Wei-Shau Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-05       Impact factor: 11.205

View more
  37 in total

1.  Impaired immune evasion in HIV through intracellular delays and multiple infection of cells.

Authors:  Christian L Althaus; Rob J De Boer
Journal:  Proc Biol Sci       Date:  2012-04-04       Impact factor: 5.349

2.  Suboptimal provirus expression explains apparent nonrandom cell coinfection with HIV-1.

Authors:  Christelle Brégnard; Gregory Pacini; Olivier Danos; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

3.  Effect of different modes of viral spread on the dynamics of multiply infected cells in human immunodeficiency virus infection.

Authors:  Dominik Wodarz; David N Levy
Journal:  J R Soc Interface       Date:  2010-07-21       Impact factor: 4.118

4.  HIV dynamics with multiple infections of target cells.

Authors:  Narendra M Dixit; Alan S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-31       Impact factor: 11.205

5.  HIV recombination: what is the impact on antiretroviral therapy?

Authors:  Christophe Fraser
Journal:  J R Soc Interface       Date:  2005-12-22       Impact factor: 4.118

6.  Drug effectiveness explained: the mathematics of antiviral agents for HIV.

Authors:  Alan S Perelson; Steven G Deeks
Journal:  Sci Transl Med       Date:  2011-07-13       Impact factor: 17.956

7.  Latent HIV-1 can be reactivated by cellular superinfection in a Tat-dependent manner, which can lead to the emergence of multidrug-resistant recombinant viruses.

Authors:  Daniel A Donahue; Sophie M Bastarache; Richard D Sloan; Mark A Wainberg
Journal:  J Virol       Date:  2013-06-26       Impact factor: 5.103

8.  Nonlinear trade-offs allow the cooperation game to evolve from Prisoner's Dilemma to Snowdrift.

Authors:  Lin Chao; Santiago F Elena
Journal:  Proc Biol Sci       Date:  2017-05-17       Impact factor: 5.349

Review 9.  T cell virological synapses and HIV-1 pathogenesis.

Authors:  Benjamin K Chen
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

10.  Incomplete inhibition of HIV infection results in more HIV infected lymph node cells by reducing cell death.

Authors:  Laurelle Jackson; Jessica Hunter; Sandile Cele; Isabella Markham Ferreira; Andrew C Young; Farina Karim; Rajhmun Madansein; Kaylesh J Dullabh; Chih-Yuan Chen; Noel J Buckels; Yashica Ganga; Khadija Khan; Mikael Boulle; Gila Lustig; Richard A Neher; Alex Sigal
Journal:  Elife       Date:  2018-03-20       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.